Unlikely IMO. I think this would require individu

Unlikely IMO. I think this would require individual INDs and would only be accomplished in special circumstances given the time, difficulty and costs associated. I could definitely be wrong, but that seems to be the precedence they established with the current 50-70 patients waiting for this basket trial approval.

I recall NP clearly outlining the ways which a patient was able to gain access to lero......going from memory:

1) Trail (TNBC or basket cancer and meeting enrollment criteria.....for TNBC this was naive TNBC patient and positive CCR5 screening)
2) Emergency patient for approved trial (i.e. non-naive TNBC patient.....meaning they can grant access based on approved IND and positive CCR5 screening, but the patient did not meet the trail protocol of naive TNBC patient)
3) Individual IND (could be any cancer that doesn't meet criteria of 1 or 2, but requires individual IND approval and cost $$.....this was obviously M-i-L and likely the only one individual IND filed thus far other than the very first patient who was later removed due to not having CCR5 on the primary tumor, but had it on the macrophages surrounding the tumor).

I believe now with the basket trial approved they can enroll all solid tumor cancers outlined in the IND under either trial or emergency protocol as long as they test positive for CCR5 in the screening process. No additional IND or approval required.

Please do your own due diligence. All my posts and comments are not to be considered investment advice.